Based on Shockwave’s recognition on Fast Company’s 2022 list of the World’s Most Innovative Companies in the medical device sector for “bringing good vibrations to heart procedures,” we sat down with Shockwave CEO Doug Godshall for a Q&A to discuss how innovation is fostered at SWAV and why continual innovation is imperative to the future success of the company.
You can also read more about the honor in the company’s press release, in which Doug is quoted saying, “Shockwave Medical was founded with innovation at our core…not only for pioneering revolutionary and proprietary IVL technology, but also for the ways that innovation permeates every aspect of our business. We are continually evolving and transforming how we do things as we seek to astound our customers with life changing products for the treatment of calcified cardiovascular disease.”
Read More
Topics:
Shockwave Behind-the-Scenes,
Coronary IVL,
Peripheral IVL,
IVL Technology,
ChalkTalk Podcast
Dr. B. Clay Sizemore, Interventional Cardiologist at Cardiovascular Consultants of South Georgia, Thomasville, GA speaks about his experience with coronary IVL in a no surgical backup hospital, discussing his patient selection criteria, importance of same day discharge and how IVL fits well into this strategy, thereby allowing the treatment of previously undilatable calcified lesions and minimizing the risk of patient transfer and procedure staging.
Read More
Topics:
Coronary IVL,
Coronary Cases,
Shockwave C2,
Coronary IVL - U.S.,
Calcium Corner
Disrupt CAD Pooled Gender Analysis is now in published in JSCAI - the new journal of the Society for Cardiovascular Angiography & Interventions. Read the JSCAI publication here: https://www.jscai.org/article/S2772-9303(21)00011-9/fulltext
Read More
Topics:
Coronary IVL,
IVL Case,
IVL Technology,
Coronary Cases,
Shockwave C2,
Coronary IVL - U.S.
The one-year Disrupt CAD III data has been published in JSCAI – the new journal of the Society for Cardiovascular Angiography & Interventions. The new data from Disrupt CAD III confirm the consistency of the excellent safety and effectiveness outcomes at 30 days out to one year.
Read More
Topics:
Coronary IVL,
IVL Case,
IVL Technology,
Coronary Cases,
Shockwave C2,
Coronary IVL - U.S.
2021 was Shockwave’s best year yet! Although it brought challenges, with it came immense opportunities which allowed us to grow and exceed expectations. As we push on into 2022, we are excited for what the year will bring but most importantly, for the opportunities to continue to help improve patient outcomes across the globe. But before we get started, let’s review the highlights of last quarter. We released four data releases, including our 1-year results of our Coronary IVL pivotal study at TCT this year, making it a monumental event. We had some exciting peer-reviewed publications come out, enrolled the first patient in the Disrupt BTK II Study, and much more. Read the latest PulsePoint for all the updates!
Read More
Topics:
Coronary IVL,
IVL Case,
Peripheral IVL,
IVL Technology,
Coronary Cases,
Peripheral Cases,
Shockwave C2,
Shockwave M5,
Shockwave S4,
PulsePoint Newsletter,
Coronary IVL - U.S.
Alternative access strategies in TAVI are prone to higher complication rates when compared to transfemoral access. This leads to the question; should physicians tackle difficult transfemoral over alternative access?
Read More
Topics:
Peripheral IVL,
Peripheral Cases,
Peripheral Conferences,
Peripheral Clinical Data
Dr. Margaret McEntegart, Consultant Interventional Cardiologist at West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital and Honorary Associate Clinical Professor, University of Glasgow, Glasgow, United Kingdom speaks about her experience with coronary IVL including practice-changing findings from her research comparing costs and resource utilization of rotational atherectomy vs. coronary Intravascular Lithotripsy.
Read More
Topics:
Coronary IVL,
Coronary Cases,
Shockwave C2,
Coronary IVL - U.S.,
Calcium Corner
For the first time, Shockwave Medical participated in ASIA-PCR, which was entirely virtual because of the ongoing COVID-19 pandemic. Watch our joint symposium with Abiomed entitled: “THE CHALLENGES OF COMPLEX PCI TREATMENT: Mechanical support in CHIP patients and IVL for calcified coronary disease”.
Read More
Topics:
Coronary IVL,
IVL Case,
IVL Technology,
Coronary Cases,
Shockwave C2,
Coronary IVL - U.S.
Great news! The Centers for Medicare and Medicaid Services (CMS) has increased payment for peripheral IVL procedures. The increases apply to procedures performed in anatomical locations above the knee in a hospital outpatient setting. The changes go into effect on January 1, 2022.
Read More
Topics:
Peripheral IVL,
Peripheral Cases,
Peripheral Clinical Data
In the latest ChalkTalk podcast, we’re going to listen in on a sponsored discussion that took place with TCTMD during TCT21 about new insights on the latest Coronary IVL data that was presented during the meeting with Drs. Ajay Kirtane, Alexandra Lansky, Matthew Price, and Ziad Ali. Hope you enjoy the conversation and for more information on the data, please visit LetsGetCracking.com.
Read More
Topics:
Shockwave Behind-the-Scenes,
Coronary IVL,
Peripheral IVL,
IVL Technology,
ChalkTalk Podcast
